Tqzjgjmerzm3dium5s0r biovasc graphica3 358x275 jpeg

BioVasc Inc.

San Francisco, CA, US

BioVasc Inc. is a clinical development consultancy, accelerator and startup incubator for emerging BioPharma | Biotech | Medtech | Nutratech companies.

Many biomedical startups are seeking to rapidly obtain robust, meaningful clinical data on their technologies, greatly enhancing their valuations, without breaking the bank (we speak Startups!). Services include protocol development and active study execution for human proof of concept (POC) and first-in-human (FIH) studies, alignment of preclinical and nonclinical studies to support FIH (we speak Science!), coordination with regulatory affairs, business development and other key stakeholders for harmonization of objectives, execution of active phase clinical studies, and safety and medical monitoring of human studies (we speak Clinical!).

BioVasc Inc. has not listed any services.

Clinical Trials, Consulting, and Management
Price on request

Special expertise in preclinical, translational and clinical development of new therapeutic products (biomolecules, small molecule drugs and medical devices), with notable expertise at the opportunity-rich convergence of biopharma & medical devices.

Special expertise in preclinical, translational and clinical development of new therapeutic products (biomolecules, small molecule drugs and medical devices), with notable expertise at the opportunity-rich convergence of biopharma & medical devices.

« Show less
Human
Obesity & Diabetes
Biology
Drug discovery
CNS/Neurology
Pain
Neuropathic Pain
Blood
Genomics
Anti-aging
neurodegenerative disorders
cardiovascular
drug metabolism
Diseased human tissue
Normal Human tissue
Biomarker analysis
Drug-Gene Interaction
clinical data
Cardiac Function
drug safety
Bioavailability Studies
Drug Safety and Toxicology
bioactivity testing
bioassay
Drug development
all therapeutic areas
Drug-drug interaction
First-in-human (FIH) Studies
Human Proof of Concept (POC) Studies
Clinical Trials
randomized clinical trial
clinical pharmacology
First-in-human (FIH) Studies
Human Proof of Concept (POC) Studies
small molecule drugs
biomolecule drugs
adverse events
treatment-emergent adverse events (TEAE)
medical device
Clinical Affairs
Medical Affairs
Clinical Research
Clinical Trial Monitoring
Price on request

Medical Monitor, Safety and study team physician role during active study phases; post-study clinical safety and results analysis, reporting, publication.

Medical Monitor, Safety and study team physician role during active study phases; post-study clinical safety and results analysis, reporting, publication.

« Show less
Safety Pharmacology & Efficacy Testing
Price on request

Clinical studies: first-in-human (FIH), human proof of concept (huPOC), PK, biomarker response, early stage (Ph1,2) safety, tolerability and efficacy studies.

Clinical studies: first-in-human (FIH), human proof of concept (huPOC), PK, biomarker response, early stage (Ph1,2) safety, tolerability and efficacy studies.

« Show less
Custom Protocols
Price on request

Protocol development and design; I speak science (molecular pharmacology background) and engineering (med device experience), facilitating interfaces with preclinical and nonclinical R&D teams for effective translation to human POC studies.

Protocol development and design; I speak science (molecular pharmacology background) and engineering (med device experience), facilitating interfaces with preclinical and nonclinical R&D teams for effective translation to human POC studies.

« Show less
Phase I clinical trials
Price on request

Clinical studies: first-in-human (FIH), human proof of concept (huPOC), PK, biomarker response, early stage (Ph1,2) safety, tolerability and efficacy studies.

Clinical studies: first-in-human (FIH), human proof of concept (huPOC), PK, biomarker response, early stage (Ph1,2) safety, tolerability and efficacy studies.

« Show less
Phase II clinical trials
Price on request

Clinical studies: first-in-human (FIH), human proof of concept (huPOC), PK, biomarker response, early stage (Ph1,2) safety, tolerability and efficacy studies.

Clinical studies: first-in-human (FIH), human proof of concept (huPOC), PK, biomarker response, early stage (Ph1,2) safety, tolerability and efficacy studies.

« Show less
Preclinical Study Design
Price on request

Preclinical, regulatory and toxicology study input as Clinical functionality contributing to team, and/or full design and execution (with respective CROs).

Preclinical, regulatory and toxicology study input as Clinical functionality contributing to team, and/or full design and execution (with respective CROs).

« Show less
Regulatory Affairs Services
Price on request

Support Regulatory Affairs (or identify and contract with colleagues) for writing, PIND meeting(s), and submission of IND or IDE (Investigational New Drug or Investigational Device Exemption) for study at hand.

Support Regulatory Affairs (or identify and contract with colleagues) for writing, PIND meeting(s), and submission of IND or IDE (Investigational New Drug or Investigational Device Exemption) for study at hand.

« Show less
IRB review
Institutional Review Board review
Price on request

IRB (institutional review board) and DSMC (drug/device safety monitoring committee) onboarding, approvals, participation.

IRB (institutional review board) and DSMC (drug/device safety monitoring committee) onboarding, approvals, participation.

« Show less
Scientific Advisory Board Management
Price on request

KOL and Advisory Board identification, interface and integration into strategic discussions, protocol and post-study analysis input, and study execution.

KOL and Advisory Board identification, interface and integration into strategic discussions, protocol and post-study analysis input, and study execution.

« Show less
Business Development Consulting
Price on request

Support Business Development with conveyance of value-add by the new clinical data in terms of company valuation, market positioning and medical/clinical value.

Support Business Development with conveyance of value-add by the new clinical data in terms of company valuation, market positioning and medical/clinical value.

« Show less
Project Management & Consulting Services
Price on request
Request a quote for more information about this service.
Animal Models and Studies
Price on request
Request a quote for more information about this service.
Clinical Research
Price on request
Request a quote for more information about this service.
Pharmacology & Toxicology
Price on request
Request a quote for more information about this service.
Business & Legal Consulting
Price on request
Request a quote for more information about this service.
Process Consulting
Price on request
Request a quote for more information about this service.
Research Management
Price on request
Request a quote for more information about this service.
Ask A Question Find what you're looking for? If not, you can ask this lab a question:

BioVasc Inc. has not received any ratings.

Be the first to endorse BioVasc Inc.

Endorse this lab